U.S. Wireless Telecom Stock News

NasdaqGS:TEAM
NasdaqGS:TEAMSoftware

Is It Time To Reconsider Atlassian (TEAM) After Its Steep 1‑Year Share Price Fall

Wondering whether Atlassian at around US$71.55 is starting to look interesting or still expensive? This breakdown will help you frame the price against what you are actually getting. The stock has moved 6.9% over the last 7 days and 7.7% over the last 30 days, yet year to date it shows a 53.8% decline and a 68.7% decline over the last year. Recent headlines have focused on Atlassian's position within the broader software sector and how sentiment around collaboration and productivity tools is...
NYSE:CRGY
NYSE:CRGYOil and Gas

A Look At Crescent Energy (CRGY) Valuation After Merger Momentum And Earnings Expectations

Recent institutional commentary put Crescent Energy (CRGY) in focus after its merger with Vital Energy, citing its free cash flow, larger scale, and support from higher oil prices tied to recent geopolitical tensions. See our latest analysis for Crescent Energy. The share price has moved to $12.73, with a 90 day share price return of 46.15% and a year-to-date share price return of 49.59%. The 1 year total shareholder return of 53.35% points to strong recent momentum, which contrasts with a...
NYSE:MCO
NYSE:MCOCapital Markets

Is Moody's (MCO) Share Price Around US$456 Still Offering Upside Potential?

Wondering if Moody's at around US$456 per share is priced for opportunity or already reflects the story investors care about most? This article focuses squarely on what you are paying versus what you may be getting. The stock has recently shown mixed signals, with a 0.2% return over the last 7 days, 6.5% over 30 days, an 8.6% decline year to date, and a 4.8% return over 1 year, alongside longer term figures of 49.3% over 3 years and 45.5% over 5 years. Recent coverage around Moody's has kept...
NYSE:ONON
NYSE:ONONLuxury

Assessing On Holding’s (ONON) Valuation As Growth Meets Premium Multiples

Recent share performance and growth snapshot On Holding (ONON) has drawn fresh attention after a mixed stretch in its share performance, with a small 1 day gain alongside negative returns over the past week, past 3 months and year to date. At a last close of US$36.25, the company carries a market value of about US$12b and reports annual revenue of US$3,014.0m and net income of US$203.7m, supported by double digit annual growth figures in both lines. See our latest analysis for On...
NasdaqGS:BL
NasdaqGS:BLSoftware

The Bull Case For BlackLine (BL) Could Change Following Its New AI ‘Glass Box’ Finance Platform

Earlier this month, BlackLine announced Agentic Financial Operations, a new AI-driven operating model for finance and accounting, alongside a dedicated New York AI Innovation Hub focused on transparent, auditable automation. The “glass box” architecture, combining Studio360 workflow orchestration with Verity AI agents and a certified system of record, aims to make AI-driven finance processes both highly automated and fully traceable for auditors and CFOs. Next, we’ll examine how BlackLine’s...
NYSE:WU
NYSE:WUDiversified Financial

Western Union Reshapes Remittances With Digital Deals And New Stablecoin

Western Union (NYSE:WU) is advancing its digital transformation with acquisitions in Mexico and Singapore focused on digital payments. The company has introduced a proprietary USDPT stablecoin to handle internal settlements across its network. Western Union is also rolling out AI driven efficiency programs and cost synergies alongside these changes during a period of challenging earnings. Western Union, trading at around $8.9, is in the middle of reshaping its long standing remittance...
NasdaqGS:CAPR
NasdaqGS:CAPRBiotechs

Assessing Capricor Therapeutics (CAPR) Valuation After HOPE-3 Phase 3 Data And BLA Review Progress

Capricor Therapeutics (CAPR) recently drew investor attention after presenting Phase 3 HOPE-3 data for Deramiocel in Duchenne muscular dystrophy at the 2026 American Academy of Neurology meeting, alongside an ongoing Biologics License Application review. See our latest analysis for Capricor Therapeutics. The latest HOPE-3 data and ongoing BLA review have arrived alongside strong momentum, with a 30 day share price return of 17.96%, a 90 day share price return of 52.03% and a very large 3 year...
NasdaqGM:MAZE
NasdaqGM:MAZEPharmaceuticals

Maze Therapeutics Raises Fresh Capital As R&D Plans And Valuation Diverge

Maze Therapeutics (NasdaqGM:MAZE) completed a sizable underwritten public offering of common stock and pre funded warrants. The deal drew significant participation from both new and existing institutional investors. Proceeds are earmarked to advance Maze Therapeutics' research and development programs focused on serious diseases. Maze Therapeutics, trading at a recent share price of $25.81, has experienced sharp share price swings, with a 7 day return of an 8.1% decline and a 30 day return...
NasdaqGM:FUTU
NasdaqGM:FUTUCapital Markets

How Investors Are Reacting To Futu Holdings (FUTU) Opening moomoo’s Trading Infrastructure To Personal AI Agents

Earlier this week, Futu Holdings’ platform moomoo launched Moomoo API Skills, allowing retail investors to link their personal AI agents to moomoo’s professional-grade trading infrastructure and convert natural language instructions into executable, but still manually authorized, investment strategies. This move highlights how Futu is deepening AI integration across its ecosystem, potentially reshaping user engagement by automating complex, around-the-clock investment workflows without...
NYSEAM:TMP
NYSEAM:TMPBanks

Tompkins Financial (TMP) Net Interest Margin Improvement Challenges Cautious Narratives

Tompkins Financial (TMP) opened 2026 with Q1 results that build on a strong finish to 2025, with trailing 12 month revenue of US$435.1 million and basic EPS of US$11.30 supported by Q4 2025 net income of US$96.2 million on revenue of US$193.8 million. Over the past year, revenue has moved from US$292.6 million to US$435.1 million on a trailing basis while basic EPS climbed from US$4.98 to US$11.30, alongside net profit margin at 37% versus 24.2% the prior year. This sets up a quarter where...
NasdaqCM:CORT
NasdaqCM:CORTPharmaceuticals

A Look At Corcept Therapeutics (CORT) Valuation After Lifyorli’s FDA Approval And Upcoming ROSELLA Phase 3 Data

Corcept Therapeutics (CORT) is back in focus after securing FDA approval for Lifyorli in platinum-resistant ovarian cancer and scheduling Phase 3 ROSELLA data for an oral presentation at the 2026 ASCO Annual Meeting. See our latest analysis for Corcept Therapeutics. With Lifyorli’s FDA approval and the upcoming ROSELLA Phase 3 presentation in view, Corcept’s 30-day share price return of 13.81% and year-to-date share price return of 20.58% contrast with a 1-year total shareholder return of...
NYSE:DCOM
NYSE:DCOMBanks

A Look At Dime Community Bancshares (DCOM) Valuation After Its First Quarter Earnings Surprise

Dime Community Bancshares (DCOM) is back in focus after its first quarter 2026 earnings release, where revenue and several core banking metrics moved ahead of market expectations despite a modest earnings per share shortfall. See our latest analysis for Dime Community Bancshares. The earnings beat on revenue and banking metrics has come alongside a 1 month share price return of 5.91% and a year to date share price return of 18.15%. The 1 year total shareholder return of 42.34% and 3 year...
NasdaqGS:LPLA
NasdaqGS:LPLACapital Markets

A Look At LPL Financial (LPLA) Valuation After Recent Cybersecurity Incident And Share Price Pullback

LPL Financial Holdings (LPLA) recently reported a cybersecurity incident involving unauthorized securities trades and fund transfers in some client accounts, prompting questions about operational risk and potential implications for the stock. See our latest analysis for LPL Financial Holdings. At a share price of US$320.51, LPL Financial has seen a 6.6% 1 month share price return but a 90 day share price decline of 11.5%. The 5 year total shareholder return of 109.6% points to stronger longer...
NasdaqGS:RVMD
NasdaqGS:RVMDBiotechs

Revolution Medicines Adds RM-055 And First Line Data To RAS Story

Revolution Medicines (NasdaqGS:RVMD) reported preclinical data for RM-055, a new class of catalytic RAS(ON) inhibitors that convert oncogenic RAS to an inactive state in multiple cancer models. The company also shared updated first line clinical data for daraxonrasib in untreated metastatic pancreatic cancer, supporting further Phase 3 evaluation. These announcements expand beyond prior late stage updates that focused on second line pancreatic cancer data and related financings. For...
NasdaqGS:SEDG
NasdaqGS:SEDGSemiconductor

Assessing SolarEdge Technologies (SEDG) Valuation After New Commercial Storage Launch And Earnings Anticipation

SolarEdge Technologies (SEDG) is back in focus after launching its CSS-OD 197 kWh commercial storage system for Europe and Asia, while traders also watch the stock ahead of early May earnings. See our latest analysis for SolarEdge Technologies. Recent trading has been choppy, with a 19.66% 7 day share price return, a 30 day share price decline of 10.63%, and a 46.14% year to date share price gain, alongside a very large 1 year total shareholder return and deeply negative 3 and 5 year total...
NYSE:HTGC
NYSE:HTGCCapital Markets

Assessing Hercules Capital (HTGC) Valuation After Recent Share Price Swings

Recent share performance and business scale Hercules Capital (HTGC) has seen mixed share performance recently, with a gain over the past month but a decline in the past 3 months and year to date, leaving the stock around $15.51. The company operates as a business development company focused on venture debt and growth capital. It reports about US$532.493 million in revenue and US$337.025 million in net income, with annual growth reported in both measures. Hercules Capital reports a market...
NasdaqGS:PATK
NasdaqGS:PATKAuto Components

Potential Patrick Industries LCI Merger And What It Means For Valuation

Patrick Industries (NasdaqGS:PATK) is reportedly in active merger talks with LCI Industries about a potential all stock combination. The discussions, if successful, could create a larger supplier focused on recreational vehicle components and related products. An announcement could be made soon, although no definitive agreement has been disclosed. Patrick Industries supplies components and building products primarily to the recreational vehicle sector, as well as to adjacent markets such as...
NasdaqCM:WULF
NasdaqCM:WULFSoftware

What TeraWulf (WULF)'s US$900 Million Equity Raise Means For Shareholders

TeraWulf Inc. has recently closed an upsized public offering of 54,510,000 common shares at US$19.00 each, raising roughly US$900.6 million to help fund its planned Hawesville, Kentucky data center campus, repay a bridge credit facility, and support future site acquisitions and general corporate uses. This capital raise, executed under an omnibus shelf registration and backed by a syndicate led by Morgan Stanley, signals a move to scale TeraWulf’s digital infrastructure footprint while...
NYSE:TAP
NYSE:TAPBeverage

Assessing Molson Coors Beverage (NYSE:TAP) Valuation After Recent Share Price Swings

Molson Coors Beverage (TAP) is back in focus after recent share price swings, with the stock showing mixed short term performance and a weaker past year. This has prompted investors to revisit its current fundamentals. See our latest analysis for Molson Coors Beverage. Recent trading has been choppy, with a 1 day share price return of negative 1% and a 7 day share price return of negative 4.82%. The 1 month share price return of 2.83% contrasts with a 90 day share price return of negative 14%...
NYSE:GNK
NYSE:GNKShipping

Genco And Diana Proxy Fight Puts Governance And Capital Allocation In Focus

Diana Shipping has publicly accused Genco Shipping & Trading (NYSE:GNK) of delaying its shareholder vote and using entrenchment tactics. The dispute centers on the timing of Genco’s annual meeting and how shareholder proposals, including board changes, are being handled. This escalation in the proxy contest raises questions about future control and governance at the dry bulk carrier. Genco Shipping & Trading, listed on the NYSE as GNK, operates a fleet of dry bulk vessels that move...
NYSE:HRL
NYSE:HRLFood

How Hormel’s Turkey Carve-Out and JENNIE-O Focus Will Impact Hormel Foods (HRL) Investors

Hormel Foods has completed the sale of its whole-bird turkey business to Life-Science Innovations, transferring the Melrose, Minnesota production facility, feed mill, and transportation assets, while retaining the JENNIE-O brand and value-added turkey operations. This carve-out leaves Hormel with the higher-margin, branded and processed side of its turkey portfolio, while exiting more commodity-oriented whole-bird production. Next, we’ll examine how retaining JENNIE-O’s value-added turkey...
NasdaqGM:ARRY
NasdaqGM:ARRYElectrical

Is It Time To Reassess Array Technologies (ARRY) After A 61.6% One Year Rally?

Wondering whether Array Technologies at US$8.11 is offering value or just noise? This article walks through what the current price might be saying about the stock. Over the short term, the share price move of 3.6% over 7 days and 4.9% over 30 days sits alongside a 16.2% decline year to date and a 61.6% return over the last year. Taken together, this gives you a very mixed picture. These moves come as Array Technologies continues to sit in a solar and renewables theme that regularly attracts...
NasdaqGS:IRDM
NasdaqGS:IRDMTelecom

Iridium Communications (IRDM) Is Down 6.9% After Reaffirming 2026 Outlook Despite Profit Squeeze

Iridium Communications Inc. has reported past first‑quarter 2026 results, with revenue rising to US$219.06 million while net income and earnings per share declined year on year. Management reaffirmed its outlook for flat to 2% full‑year 2026 service revenue growth despite profit pressure from a revised compensation structure and softer margins. Next, we’ll examine how reaffirmed 2026 guidance amid weaker profitability reshapes Iridium’s existing investment narrative and its key growth...
NasdaqGS:CMCSA
NasdaqGS:CMCSATelecom

Has Comcast (CMCSA) Become An Opportunity After Its Prolonged Share Price Decline?

Wondering if Comcast at around US$27.56 is a potential bargain or a value trap? This article breaks down what the current price really implies for you as a shareholder. The stock has seen pressure recently, with returns of a 7.0% decline over 7 days, a 4.0% decline over 30 days, and a 6.7% decline year to date, while the 1-year and 5-year returns stand at a 9.4% decline and a 38.9% decline. Recent coverage of Comcast has focused on the business as a core telecom and media player, with...